Scientific deep-dive
GLP-1 Missed Dose: What to Do, by Drug
Missed a dose of Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, or Foundayo? Each FDA label's exact missed-dose window and rule — when to take it late, when to skip, and when a long gap means restarting low.
Missing a GLP-1 dose is common and, for the weekly injectables, usually not a problem — the labels build in a multi-day catch-up window because these drugs have a long half-life. The exact rule depends on which drug you take. Ozempic lets you take a missed weekly dose within 5 days; Mounjaro and Zepbound within 4 days (96 hours); Wegovy uses a slightly different framing — take it if your next dose is more than 2 days away. Miss the window and the instruction is the same everywhere: skip it, don't double up, and resume your regular schedule. The daily pills (Rybelsus, oral semaglutide, and Foundayo/orforglipron) work differently — you simply skip the missed day. This guide gives each drug's exact label rule, the cutoff window, and when a long gap means you need to re-titrate. Every rule below is quoted from the current FDA label via DailyMed.
The quick answer
- Weekly injections have a catch-up window. Ozempic: take it within 5 days[1]. Mounjaro and Zepbound: within 4 days / 96 hours[3][4]. Wegovy injection: take it if the next scheduled dose is more than 2 days away[2]. Past the window, skip and resume your normal day.
- Daily pills are simply skipped. For Rybelsus (oral semaglutide) and oral Ozempic, “skip the missed dose and take the next dose the following day”[5]. For Foundayo (orforglipron), take it as soon as possible but never double up[6].
- Never double up. No GLP-1 label tells you to take two doses to make up for one — that just raises the odds of nausea and vomiting.
- A long gap may mean restarting low. If you miss many consecutive doses, some labels tell you (or your prescriber) to restart at a lower dose and re-climb the ladder, because your gut tolerance resets (Wegovy injection[2]; Foundayo[6]).
- Why the window exists: the weekly drugs have a roughly week-long half-life, so a dose taken a day or two late still lands inside the same therapeutic range — see how long a GLP-1 stays in your system.
Missed-dose rules by drug
The table below is the practical reference. Each rule is quoted or paraphrased directly from that drug's current FDA Dosage & Administration section, retrieved from DailyMed (the SetIDs are listed in the references). When in doubt, follow your own label and prescriber — generic and authorized-generic versions can carry slightly different wording.
| Drug (generic) | Schedule | Catch-up window | What to do |
|---|---|---|---|
| Ozempic (semaglutide injection) | Once weekly | Within 5 days of the missed dose | Take it as soon as possible within 5 days; if more than 5 days have passed, skip it and take the next dose on the regularly scheduled day, then resume weekly[1] |
| Wegovy (semaglutide injection) | Once weekly | If next dose is > 2 days away | If the next scheduled dose is more than 2 days away, take it as soon as possible; if less than 2 days away, skip it and resume on the regular day[2] |
| Mounjaro (tirzepatide injection) | Once weekly | Within 4 days (96 hours) | Take it as soon as possible within 4 days; if more than 4 days have passed, skip it and resume the weekly schedule[3] |
| Zepbound (tirzepatide injection) | Once weekly | Within 4 days (96 hours) | Take it as soon as possible within 4 days; if more than 4 days have passed, skip it and resume the weekly schedule[4] |
| Rybelsus / oral Ozempic (oral semaglutide) | Once daily | No catch-up — skip | “Skip the missed dose and take the next dose the following day”[5] |
| Wegovy tablet (oral semaglutide) | Once daily | No catch-up — skip | Skip the missed dose and take the next dose the following day[2] |
| Foundayo (orforglipron) | Once daily | Same day, ASAP | Take the missed dose as soon as possible; do not double up the next dose[6] |
Weekly injections: take it within the window, then move on
For the weekly GLP-1 injections, the FDA labels are explicit and reassuring. The Ozempic label says: “If a dose is missed, administer OZEMPIC as soon as possible within 5 days after the missed dose. If more than 5 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day. In each case, patients can then resume their regular once-weekly dosing schedule”[1]. Mounjaro and Zepbound use the same structure with a slightly shorter window — “as soon as possible within 4 days (96 hours) after the missed dose”, otherwise skip and resume[3][4].
Wegovy phrases it from the other direction. Its label says that if a dose of Wegovy injection is missed and the next scheduled dose is “more than 2 days away, administer WEGOVY injection as soon as possible”; if it is “less than 2 days away,” skip it and “resume dosing on the regularly scheduled day of the week”[2]. In practice that lands close to the same place as the others: a dose that is only a day or two late can be taken; a dose that is nearly a full week late is skipped. The key reset rule across all of them is the day of the week — once you skip, your dosing day stays put.
Why a late weekly dose is usually fine
Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have a half-life of about a week, which is exactly why they're dosed weekly. A dose taken a day or two late still overlaps with the previous one in your bloodstream, so drug levels barely dip. That long tail is the pharmacologic reason the labels can offer a multi-day catch-up window instead of telling you to skip immediately. See how long a GLP-1 stays in your system for the half-life details.
Daily pills: just skip the missed day
The oral GLP-1s are different because they clear faster and are dosed every day. For Rybelsus and oral Ozempic the label is one sentence: “If a dose is missed, skip the missed dose and take the next dose the following day”[5]. There is no catch-up window — you don't take a delayed pill later that day, and you never take two the next day. Remember these tablets also have to be taken on an empty stomach with no more than 4 ounces of water, waiting at least 30 minutes before eating, drinking, or other medications[5] — another reason a forgotten dose is simply skipped rather than crammed in later.
Foundayo (orforglipron), the once-daily oral GLP-1, is slightly more forgiving: its label says “If a dose is missed, instruct patients to take the dose as soon as possible” and to “not double up the next dose”[6]. It can be taken with or without food, which makes a same-day catch-up practical[6].
When you miss many doses in a row
A single late dose is trivial; a long gap is where it matters, because your gut's tolerance to GLP-1 side effects fades when you stop. Restarting at your old dose after a break can bring back the nausea and vomiting you got past during titration — so some labels build in a restart-low rule.
- Wegovy injection: “If 2 or more consecutive doses… are missed, resume dosing as scheduled or, if needed, reinitiate… and follow the dosage escalation schedule, which may reduce the occurrence of gastrointestinal adverse reactions associated with reinitiation of treatment”[2].
- Foundayo (orforglipron): “If 7 or more consecutive doses are missed, reinitiate dosage escalation at a lower dosage to reduce the risk of gastrointestinal adverse reactions”[6].
- Ozempic, Mounjaro, Zepbound: the labels don't spell out a fixed re-titration trigger for missed weekly doses, but the same tolerance logic applies — after a long interruption, prescribers commonly restart at a lower dose and re-climb the ladder. Ask yours before resuming after a gap of several weeks.
If you take a GLP-1 for type 2 diabetes
For weight-only use, a missed dose mostly means a brief pause in appetite suppression. If you take a GLP-1 for blood-sugar control, a gap can let glucose drift up — and if you also use insulin or a sulfonylurea, the interaction between agents can shift. Don't skip glucose monitoring during a missed-dose stretch, and check with your prescriber about whether other diabetes medications need adjusting.
Bottom line
For the weekly GLP-1 injections, a late dose taken inside the labeled window is fine — 5 days for Ozempic[1], 4 days for Mounjaro and Zepbound[3][4], and “more than 2 days away” for Wegovy[2]. Miss the window and you skip it, resume your normal day, and never double up. For the daily pills, you simply skip the missed day[5][6]. A single miss rarely matters; a long string of missed doses can reset your side-effect tolerance, and labels for Wegovy injection and Foundayo tell you to restart lower and re-titrate[2][6]. When in doubt, follow your specific label and your prescriber — especially if you take the drug for diabetes.
This article is educational and is not medical advice. Every missed-dose rule above is quoted or paraphrased from the current FDA prescribing information for that drug, retrieved verbatim from the NIH DailyMed database (SetIDs in the references) and verified before publication. Labels are updated periodically and authorized-generic versions may differ — always follow the instructions that came with your medication and your prescriber's guidance.
References
- 1.Novo Nordisk Pharmaceutical Industries, LP. OZEMPIC (semaglutide) injection — Highlights of Prescribing Information, §2.1 Dosage and Administration (missed dose). FDA label via DailyMed, SetID adec4fd2-6858-4c99-91d4-531f5f2a2d79. FDA label via DailyMed. 2026.
- 2.Novo Nordisk Pharmaceutical Industries, LP. WEGOVY (semaglutide) injection and tablet — Highlights of Prescribing Information, §2.4 Dosage and Administration (missed dose; reinitiation after consecutive missed doses). FDA label via DailyMed, SetID ee06186f-2aa3-4990-a760-757579d8f77b. FDA label via DailyMed. 2026.
- 3.Eli Lilly and Company. MOUNJARO (tirzepatide) injection — Highlights of Prescribing Information, §2.1 Dosage and Administration (missed dose). FDA label via DailyMed, SetID d2d7da5d-ad07-4228-955f-cf7e355c8cc0. FDA label via DailyMed. 2026.
- 4.Eli Lilly and Company. ZEPBOUND (tirzepatide) injection — Highlights of Prescribing Information, §2.3 Dosage and Administration (missed dose). FDA label via DailyMed, SetID 487cd7e7-434c-4925-99fa-aa80b1cc776b. FDA label via DailyMed. 2026.
- 5.Novo Nordisk Pharmaceutical Industries, LP. RYBELSUS / OZEMPIC (oral semaglutide) tablet — Highlights of Prescribing Information, Dosage and Administration (missed dose; administration on empty stomach). FDA label via DailyMed, SetID 27f15fac-7d98-4114-a2ec-92494a91da98. FDA label via DailyMed. 2026.
- 6.Eli Lilly and Company. FOUNDAYO (orforglipron) tablet — Highlights of Prescribing Information, Dosage and Administration (missed dose; reinitiation after 7+ consecutive missed doses). FDA label via DailyMed, SetID 8ac446c5-feba-474f-a103-23facb9b5c62. FDA label via DailyMed. 2026.